You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population: The 3-City Study
|
|---|---|
| Published in |
JAMA Internal Medicine, July 2009
|
| DOI | 10.1001/archinternmed.2009.229 |
| Pubmed ID | |
| Authors |
Isabelle Carrière, Annie Fourrier-Reglat, Jean-François Dartigues, Olivier Rouaud, Florence Pasquier, Karen Ritchie, Marie-Laure Ancelin |
| Abstract |
Despite the high intake of medications with anticholinergic properties by community-dwelling elderly persons, the effects on cognitive decline and dementia have rarely been evaluated. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 33% |
| United Kingdom | 3 | 20% |
| France | 1 | 7% |
| Spain | 1 | 7% |
| Georgia | 1 | 7% |
| Unknown | 4 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 73% |
| Practitioners (doctors, other healthcare professionals) | 4 | 27% |
Mendeley readers
The data shown below were compiled from readership statistics for 222 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 1% |
| Brazil | 2 | <1% |
| Netherlands | 1 | <1% |
| Italy | 1 | <1% |
| Spain | 1 | <1% |
| India | 1 | <1% |
| Unknown | 213 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 35 | 16% |
| Student > Master | 31 | 14% |
| Other | 24 | 11% |
| Student > Ph. D. Student | 23 | 10% |
| Student > Bachelor | 21 | 9% |
| Other | 56 | 25% |
| Unknown | 32 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 89 | 40% |
| Neuroscience | 22 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 18 | 8% |
| Psychology | 14 | 6% |
| Nursing and Health Professions | 9 | 4% |
| Other | 22 | 10% |
| Unknown | 48 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 55. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2024.
All research outputs
#784,457
of 25,837,817 outputs
Outputs from JAMA Internal Medicine
#2,616
of 11,730 outputs
Outputs of similar age
#2,005
of 125,463 outputs
Outputs of similar age from JAMA Internal Medicine
#5
of 32 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,730 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 85.0. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 125,463 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.